Matt Hancock calls new Omicron South Africa data on antibodies 'very worrying'

A new study from South Africa has shown that antibodies from the Pfizer vaccine can be up to 40 times less effective against Omicron then against the original strain of Covid-19, which Matt Hancock is calling "very worrying".